Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.

Heinrich L, Birkner T, Abraham S, Gerdes S, Honstein T, Müller S, Augustin M, Harder I, Schaefer T, Pinter A, Bong A, Ramaker-Brunke J, Biedermann T, Sticherling M, Gorriahn-Maiterth H, Schäkel K, Schwarz B, Quist S, Asefi M, Adler N, Stahl M, Schulz-Kiesow M, Schenck F, Werfel T, Weidinger S, Heratizadeh A, Schmitt J

Open source

DOI: 10.1093/skinhd/vzaf075
Published: 2025 Dec
Container: Skin health and disease
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/skinhd/vzaf075,
  title = {Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.},
  author = {Heinrich L and Birkner T and Abraham S and Gerdes S and Honstein T and Müller S and Augustin M and Harder I and Schaefer T and Pinter A and Bong A and Ramaker-Brunke J and Biedermann T and Sticherling M and Gorriahn-Maiterth H and Schäkel K and Schwarz B and Quist S and Asefi M and Adler N and Stahl M and Schulz-Kiesow M and Schenck F and Werfel T and Weidinger S and Heratizadeh A and Schmitt J},
  year = {2025},
  journal = {Skin health and disease},
  doi = {10.1093/skinhd/vzaf075},
  url = {https://doi.org/10.1093/skinhd/vzaf075}
}

RIS

TY  - JOUR
TI  - Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.
AU  - Heinrich L
AU  - Birkner T
AU  - Abraham S
AU  - Gerdes S
AU  - Honstein T
AU  - Müller S
AU  - Augustin M
AU  - Harder I
AU  - Schaefer T
AU  - Pinter A
AU  - Bong A
AU  - Ramaker-Brunke J
AU  - Biedermann T
AU  - Sticherling M
AU  - Gorriahn-Maiterth H
AU  - Schäkel K
AU  - Schwarz B
AU  - Quist S
AU  - Asefi M
AU  - Adler N
AU  - Stahl M
AU  - Schulz-Kiesow M
AU  - Schenck F
AU  - Werfel T
AU  - Weidinger S
AU  - Heratizadeh A
AU  - Schmitt J
PY  - 2025
JO  - Skin health and disease
DO  - 10.1093/skinhd/vzaf075
UR  - https://doi.org/10.1093/skinhd/vzaf075
ER  -

APA

L, H., T, B., S, A., S, G., T, H., S, M., M, A., I, H., T, S., A, P., A, B., J, R., T, B., M, S., H, G., K, S., B, S., S, Q., M, A., N, A., M, S., M, S., F, S., T, W., S, W., A, H., & J, S. (2025). Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.. Skin health and disease. https://doi.org/10.1093/skinhd/vzaf075

Source records

pubmed · retrieved 2026-09-25T12:14:14.217Z